loadpatents
Patent applications and USPTO patent grants for Mazdiyasni; Hormoz.The latest application filed is for "heteroaryl compounds and uses thereof".
Patent | Date |
---|---|
2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 11,351,168 - Singh , et al. June 7, 2 | 2022-06-07 |
Substituted 2,4-diaminopyrimidines as kinase inhibitors Grant 10,828,300 - Singh , et al. November 10, 2 | 2020-11-10 |
Heteroaryl compounds and uses thereof Grant 10,774,052 - D'Agostino , et al. September 15, 2 | 2020-09-15 |
Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases Grant 10,618,902 - D'Agostino , et al. | 2020-04-14 |
2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 10,596,172 - Singh , et al. | 2020-03-24 |
Heteroaryl Compounds And Uses Thereof App 20190375719 - D'Agostino; Laura Akullian ;   et al. | 2019-12-12 |
Heteroaryl Compounds And Uses Thereof App 20190218220 - D'Agostino; Laura Akullian ;   et al. | 2019-07-18 |
Heteroaryl Compounds And Uses Thereof App 20190192512 - Singh; Juswinder ;   et al. | 2019-06-27 |
Heteroaryl Compounds And Uses Thereof App 20190117650 - Singh; Juswinder ;   et al. | 2019-04-25 |
Heteroaryl compounds and uses thereof Grant 10,189,794 - D'Agostino , et al. Ja | 2019-01-29 |
Substituted pyrido[2,3-d]pyrimidines as inhibitors of protein kinases Grant 10,065,966 - D'Agostino , et al. September 4, 2 | 2018-09-04 |
2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 10,010,548 - Singh , et al. July 3, 2 | 2018-07-03 |
Substituted 2,4-diaminopyrimidines as kinase inhibitors Grant 9,987,276 - Singh , et al. June 5, 2 | 2018-06-05 |
Heteroaryl Compounds And Uses Thereof App 20180022713 - D'Agostino; Laura Akullian ;   et al. | 2018-01-25 |
Heteroaryl Compounds And Uses Thereof App 20170267685 - D'Agostino; Laura Akullian ;   et al. | 2017-09-21 |
Heteroaryl compounds and uses thereof Grant 9,695,132 - D'Agostino , et al. July 4, 2 | 2017-07-04 |
Substituted pyrido[2,3-d]pyrimidines as protein kinase inhibitors Grant 9,663,524 - D'Agostino , et al. May 30, 2 | 2017-05-30 |
Heteroaryl Compounds And Uses Thereof App 20170100397 - Singh; Juswinder ;   et al. | 2017-04-13 |
Heteroaryl Compounds And Uses Thereof App 20160303121 - Singh; Juswinder ;   et al. | 2016-10-20 |
2,4-disubstituted pyrimidines as kinase inhibitors Grant 9,409,921 - Singh , et al. August 9, 2 | 2016-08-09 |
Heteroaryl Compounds And Uses Thereof App 20160221966 - D'Agostino; Laura Akullian ;   et al. | 2016-08-04 |
Heteroaryl compounds and uses thereof Grant 9,321,786 - D'Agostino , et al. April 26, 2 | 2016-04-26 |
Substituted 2,4-diaminopyrimidines as kinase inhibitors Grant 9,296,737 - Singh , et al. March 29, 2 | 2016-03-29 |
Heteroaryl Compounds And Uses Thereof App 20160046634 - D'Agostino; Laura Akullian ;   et al. | 2016-02-18 |
Substituted 2,4-diaminopyrimidines as kinase inhibitors Grant 9,212,181 - Singh , et al. December 15, 2 | 2015-12-15 |
Methods Of Treating A Bruton's Tyrosine Kinase Disease Or Disorder App 20150216865 - Westlin, III; William Frederick ;   et al. | 2015-08-06 |
Heteroaryl Compounds And Uses Thereof App 20140296233 - D'Agostino; Laura Akullian ;   et al. | 2014-10-02 |
Heteroaryl Compounds And Uses Thereof App 20140213574 - Singh; Juswinder ;   et al. | 2014-07-31 |
2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 8,710,222 - Singh , et al. April 29, 2 | 2014-04-29 |
2,4-diaminopyrimidines useful as kinase inhibitors Grant 8,609,679 - Singh , et al. December 17, 2 | 2013-12-17 |
Heteroaryl Compounds And Uses Thereof App 20130165462 - Singh; Juswinder ;   et al. | 2013-06-27 |
2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 8,450,335 - Singh , et al. May 28, 2 | 2013-05-28 |
Heteroaryl Compounds And Uses Thereof App 20130072469 - Singh; Juswinder ;   et al. | 2013-03-21 |
Heteroaryl Compounds And Uses Thereof App 20130065899 - Singh; Juswinder ;   et al. | 2013-03-14 |
Heteroaryl Compounds And Uses Thereof App 20130065879 - Singh; Juswinder ;   et al. | 2013-03-14 |
2,4-disubstituted pyrimidines useful as kinase inhibitors Grant 8,338,439 - Singh , et al. December 25, 2 | 2012-12-25 |
Pi3 Kinase Inhibitors And Uses Thereof App 20110230476 - NIU; DEQIANG ;   et al. | 2011-09-22 |
4-aminopyrrolopyrimidines as kinase inhibitors Grant 7,863,444 - Calderwood , et al. January 4, 2 | 2011-01-04 |
Ion Channel Modulators App 20100267697 - Galullo; Vincent P. ;   et al. | 2010-10-21 |
Heteroaryl Compounds And Uses Thereof App 20100249092 - Singh; Juswinder ;   et al. | 2010-09-30 |
Beta-carbolines useful for treating inflammatory disease Grant 7,727,985 - Hepperle , et al. June 1, 2 | 2010-06-01 |
Beta-carbolines Useful For Treating Inflammatory Disease App 20100093713 - Hepperle; Michael E. ;   et al. | 2010-04-15 |
Heteroaryl Compounds and Uses Thereof App 20100029610 - Singh; Juswinder ;   et al. | 2010-02-04 |
Ion channel modulators Grant 7,368,467 - Zelle , et al. May 6, 2 | 2008-05-06 |
Ion Channel Modulators App 20080090891 - Zelle; Robert ;   et al. | 2008-04-17 |
Substituted .beta.-carbolines Grant 7,348,336 - Ritzeler , et al. March 25, 2 | 2008-03-25 |
Ion Channel Modulators App 20070281937 - Zelle; Robert ;   et al. | 2007-12-06 |
Substituted beta carbolines App 20060166978 - Ritzeler; Olaf ;   et al. | 2006-07-27 |
Substituted beta-carbolines Grant 7,026,331 - Ritzeler , et al. April 11, 2 | 2006-04-11 |
Ion channel modulators App 20050203159 - Zelle, Robert ;   et al. | 2005-09-15 |
Beta-carbolines useful for treating inflammatory disease App 20040235839 - Hepperle, Michael E. ;   et al. | 2004-11-25 |
Substituted beta carbolines App 20040110759 - Ritzeler, Olaf ;   et al. | 2004-06-10 |
4-aminopyrrolopyrimidines As Kinase Inhibitors App 20030187001 - CALDERWOOD, DAVID ;   et al. | 2003-10-02 |
Substituted beta carbolines App 20020099068 - Ritzeler, Olaf ;   et al. | 2002-07-25 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.